Turn ETF ideas into real portfolios. Try the builder now →
T. Rowe Price Biotech ETF
TDNA performance and flow charts
Performance
Flows
Historic performance and flows
Data as of October 29, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +0.68% | |||||
| Flows | +$568K | - | - | - | - | - |
Characteristics
This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
| Management strategy | Active |
| Strategy | Long Only |
| Provider | T. Rowe Price |
| N° of holdings | 86 |
| Dividend policy | Distributing |
| Inception date | September 16, 2026 |
| ESG | No |
More data and info about TDNA on Trackinsight
Exposure
Data as of September 30, 2026Diversification
Total weight of top 15 holdings out of 86
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | ||||
Max drawdown | ||||
Max drawdown duration | N/A | N/A | N/A | N/A |
Time to recover | N/A | N/A | N/A | N/A |
What type of ETF is TDNA?
TDNA is a Active ETF that provides exposure to Equity assets. It is managed by T. Rowe Price.
What does TDNA invest in?
This ETF provides exposure to Other Biotechnology Equities. It is part of the segment: Uncategorized Equities.
What is the expense ratio of TDNA?
The total expense ratio (TER) of TDNA is 0.55%, representing the annual fee charged by the fund manager.
When was TDNA launched?
TDNA was launched on September 16, 2026, marking its entry into the ETF market.
Who is the issuer of TDNA?
TDNA is issued by T. Rowe Price.
What is the AUM of TDNA?
As of October 29, 2026, TDNA manages $10.69 M, reflecting the total assets held in the fund.
How many holdings are in TDNA
As of September 30, 2026, TDNA holds 86 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is TDNA?
As of September 30, 2026, TDNA holds 86 securities, with 37.16% of its assets concentrated in its top 15 holdings.
What are the top holdings of TDNA?
As of September 30, 2026, TDNA holds a portfolio of 86 underlyings, with its largest positions including argenx SE, Kymera Therapeutics, Inc. and Kodiak Sciences, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does TDNA invest in?
As of September 30, 2026, TDNA has its largest geographic exposures in USA.
What sectors or themes does TDNA focus on?
As of September 30, 2026, TDNA is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
First Look ETF
First Look ETF: Income, International, and Cash Flow ETFs
In this season 6 episode of First Look ETF, Stephanie Stanton @etfguide examines the latest ETF marketplace trends with NYSE and guests.
ETF Trends
ETF Industry KPIs October 5, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs September 28, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs September 22, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
